Biosimilar Success in an Evolving Landscape: Development Considerations for Staying Competitive
By
Kimberly Salgado
10d agoen
Source
bioprocessintl.comBiosimilar Success in an Evolving Landscape: Development Considerations for Staying Competitivebioprocessintl.comEvolution beyond traditional monoclonal antibodies and regulatory shifts are creating challenging conditions for biosimilars development. However, companies can set up their biosimilar products for success by establishing agile strategies for development, product characterization, and regulatory engagement.
You might also wanna read
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco
a16z.news·16d agoFDA Moves to Speed Biosimilar Development, Lower Prescription Drug Costs
ltcnews.com·3mo ago
Celltrion Poised for Profitability Leap on New Biosimilars
Seoul Economic Daily·2d ago
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc
writingruxandrabio.com·15d ago
Benchmarking Codon Optimization Strategies for Improved Antibody Expression
This article/webinar promotion discusses how antibody expression titers are critical for screening efficiency, developability, and manufactu
hubs.li·12d ago
Manufacturing and regulatory hurdles threaten cell and gene therapy progress
The article discusses how manufacturing and regulatory challenges are hindering the progress of cell and gene therapies, particularly in can
medium.com·23d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.